What is Amuza?
Amuza Inc operates at the intersection of advanced engineering and biological inquiry, providing high-precision research instruments tailored for the life sciences community. The company maintains a specialized portfolio that includes sophisticated tools for behavioral neuroscience, neurotransmitter analysis, and optogenetics. By delivering reliable laboratory equipment and continuous technical support, Amuza facilitates critical discoveries for researchers navigating complex experimental challenges. Their commitment to collaborative innovation ensures that their product suite remains aligned with the evolving requirements of modern scientific laboratories, effectively bridging the gap between raw data acquisition and actionable research outcomes.
How much funding has Amuza raised?
Amuza has raised a total of $130K across 1 funding round:
Debt
$130K
Debt (2021): $130K with participation from PPP
Key Investors in Amuza
PPP
Public-Private Partnership
What's next for Amuza?
With the recent infusion of capital, Amuza is poised to scale its research and development initiatives, focusing on the next generation of analytical instrumentation. The company is expected to leverage this financial momentum to expand its market reach, potentially diversifying its product offerings to address emerging trends in neurobiology and molecular research. By prioritizing strategic partnerships and technical excellence, Amuza aims to maintain its competitive edge, ensuring that its suite of laboratory solutions continues to serve as a cornerstone for high-impact scientific exploration. The focus remains on long-term value creation through sustained innovation and operational scalability.
See full Amuza company page
